Medico Remedies share price

Extreme risk
  • 74%Low risk
  • 74%Moderate risk
  • 74%Balanced risk
  • 74%High risk
  • 74%Extreme risk
  • 57.00(-3.76%)
    April 25, 2025 15:29:45 PM IST
    • NSE
    • BSE
  • Vol : 773.95K (NSE + BSE)
    Last 20 day avg : 1.50 M

Medico Remedies is trading -3.76% lower at Rs 57.00 as compared to its last closing price. Medico Remedies has been trading in the price range of 60.00 & 55.95. Medico Remedies has given 8.19% in this year & 4.52% in the last 5 days. Medico Remedies has TTM P/E ratio 51.55 as compared to the sector P/E of 30.66.The company posted a net profit of 2.62 Crores in its last quarter.Listed peers of Medico Remedies include Albert David (-3.42%), Jenburkt Pharmaceuticals (-2.71%), Medico Remedies (-3.76%).The Mutual Fund holding in Medico Remedies was at -% in . The MF holding has - from the last quarter. The FII holding in Medico Remedies was at 0.11% in 31 Mar 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Apr 25, 2025, 04:35 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    9.42
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    55.78
    Higher than historical values
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.15
    Higher than industry
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
55.95
Highest
60.00
52 week range
Lowest
35.00
Highest
79.78
Medico Remedies Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue grew in December quarter by 32.64% from Rs 39.49 crore to Rs 29.77 crore, year-on-year
    • financial-insightsThe company has grown its December quarter profit by 81.26% from Rs 1.45 crore to Rs 2.62 crore, year-on-year
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Medico Remedies Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 60.92
  • R2
  • 69.74
  • R3
  • 77.48
Pivot53.18
  • S1
  • 44.36
  • S2
  • 36.62
  • S3
  • 27.80
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Medico Remedies Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Albert David
Neutral
849.80-3.42484.396.561.31.320.16
Jenburkt Pharmaceuticals
Bearish
1,050.00-2.71467.8818.503.321.40-
Medico Remedies
-
57.00-3.76473.2457.719.14-1.66
Sms Lifesciences India
Bullish
1,439.00-5.25439.3951.072.630.1020.10
Venus Remedies
Moderately Bullish
319.25-4.59427.8915.880.93-7.93
Medico Remedies Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Medico Remedies is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 63.79%
    • InsightsPromoter(s) have decreased the stake in the company in last 12 months
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has decreased by 0.28 percentage points from previous quarter
    • InsightsMutual Funds are not invested in this company.
    Medico Remedies Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-02-05Quarterly Results
    2024-11-12Quarterly Results
    2024-08-12Quarterly Results
    2024-05-09Audited Results
    2024-02-12Quarterly Results
    About the company Medico Remedies
    • IndustryBiotechnology & Drugs
    • ISININE630Y01024
    • BSE Code540937
    • NSE CodeMEDICO
    Medico Remedies Limited is an India-based company, principally engaged in the pharmaceutical business. The Company is involved in the development, manufacture and sale of pharmaceutical and nutraceutical products. It focuses on anti-infective, Beta-Lactams, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, hematinic and other supplements. The Company also manufactures and markets capabilities in other drugs such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Pediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others. Its syrups include Medivit Syrup and Ferrovit Syrup.
    • Management Info
    • Haresh MehtaChairman of the Board, Legal Head and Chief Financial Officer
    • Hasan BohraCompany Secretary and Compliance Officer
    • Harshit MehtaManaging Director, Marketing & Export Head and Executive Director
    • Rishit MehtaProduction - Technical & Quality Control Head and Whole-time Director
    • Dayanand MathapatiAdditional Executive Director
    • Gopal JhaAdministration Manager
    • Priyal MehtaMarketing Manager
    • Dushant PandeyQuality Control Manager
    Medico Remedies Share Price FAQs

    Medico Remedies is trading at 57.00 as on Fri Apr 25 2025 09:59:45. This is -3.76% lower as compared to its previous closing price of 59.23.

    The market capitalization of Medico Remedies is 473.24 Cr as on Fri Apr 25 2025 09:59:45.

    The 52 wk high for Medico Remedies is 79.78 whereas the 52 wk low is 35.00

    Medico Remedies can be analyzed on the following key metrics -

    • TTM P/E: 51.55
    • Sector P/E: 30.66
    • Dividend Yield: 0.00%
    • D/E ratio: -

    Medico Remedies reported a net profit of 8.29 Cr in 2024.